Capecitabine

CAS 154361-50-9 25 API suppliersSmall Molecule

Overview

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of various cancers, most notably colorectal and breast cancer. It is a prodrug that is metabolized to 5-fluorouracil, a molecule that inhibits thymidylate synthase, thereby blocking DNA synthesis in rapidly dividing tumor cells.

API suppliers (25)

Suppliers of Capecitabine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India11China4Netherlands1Italy1Taiwan1USA1

Country recorded for 19 of 25 suppliers.

10 of 25 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

Oncology
Verified Supplier Partner

Do you supply Capecitabine? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.